DASHENLIN PHARMACEUTICAL GROUP CO., LTD.

ETFs DaShenLin Pharmaceutical Group Co., Ltd.

603233

CNE100002RG2

Name	YTD change	Weight	AuM
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD	+6.30%	-.--%	37 M€
DIMENSIONAL EMERGING MARKETS CORE EQUITY 2 ETF - USD	+20.59%	-.--%	9,273 M€
XTRACKERS HARVEST CSI 500 CHINA A-SHARES SMALL CAP ETF - USD	+4.03%	0.08%	35 M€
FRANKLIN EMERGING MARKET CORE DIVIDEND TILT INDEX ETF - USD	+27.66%	0.01%	92 M€
BNY MELLON EMERGING MARKETS EQUITY ETF - USD	+22.73%	0%	89 M€
L&G EMERGING MARKETS EQUITY UCITS ETF - USD	+28.61%	0%	150 M€
XTRACKERS EMERGING MARKETS CARBON REDUCTION AND CLIMATE IMPROVERS ETF - USD	+17.30%	0%	61 M€
VANGUARD FTSE EMERGING MARKETS UCITS ETF - USD	+10.29%	0%	3,667 M€
VANGUARD ESG EMERGING MARKETS ALL CAP UCITS ETF ACC - USD	+18.28%	0%	117 M€
VANGUARD FTSE EMERGING MARKETS UCITS ETF ACCUMULATING - USD	+14.73%	0%	2,339 M€
VANGUARD ESG EMERGING MARKETS ALL CAP UCITS ETF DIST - USD	+16.40%	0%	24 M€
ISHARES MSCI EM UCITS ETF (ACC) - USD	+22.57%	0%	10,007 M€
VANGUARD FTSE EMERGING MARKETS SHARES ETF - AUD	+4.28%	0%	1,449 M€
VANGUARD FTSE EMERGING MARKETS ETF - USD	+11.03%	0%	126,032 M€
VANGUARD FTSE EMERGING MARKETS ALL CAP INDEX ETF - CAD	+14.59%	0%	3,276 M€
STATE STREET SPDR PORTFOLIO EMERGING MARKETS ETF - USD	+11.28%	0%	17,649 M€
VANGUARD FTSE ALL-WORLD EX-US ETF - USD	+13.88%	0%	70,454 M€
CI EQUITY ASSET ALLOCATION ETF - CAD	+15.57%	0%	39 M€
ELM MARKET NAVIGATOR ETF - USD	+7.69%	0%	594 M€
VANGUARD FTSE GLOBAL ALL CAP EX CANADA INDEX ETF - CAD	+16.05%	0%	2,612 M€
VANGUARD TOTAL WORLD STOCK ETF - USD	+12.58%	0%	81,610 M€
RETURN STACKED GLOBAL STOCKS & BONDS ETF - USD	+6.54%	0%	526 M€
VANGUARD TOTAL INTERNATIONAL STOCK ETF - USD	+13.67%	0%	163,510 M€
ISHARES MSCI ACWI UCITS ETF - SGD HEDGED	+11.06%	0%	1,164 M€
DEFINED DURATION 20 ETF - USD	+11.51%	0%	19 M€
RPAR RISK PARITY ETF - USD	-0.42%	0%	580 M€
THE BRINSMERE FUND GROWTH ETF - USD	+8.72%	0%	391 M€
VANGUARD GROWTH ETF PORTFOLIO - CAD	+11.42%	0%	7,793 M€
VANGUARD ALL-EQUITY ETF PORTFOLIO - CAD	+15.99%	0%	12,086 M€
DISCIPLINE FUND ETF - USD	-.--%	0%	73 M€
UPAR ULTRA RISK PARITY ETF - USD	-2.65%	0%	59 M€
STATE STREET SPDR GLOBAL ALLOCATION ETF - DISTRIBUTING - USD	+6.43%	0%	317 M€
THE BRINSMERE FUND CONSERVATIVE ETF - USD	+2.22%	0%	363 M€
VANGUARD RETIREMENT INCOME ETF PORTFOLIO - CAD	+1.53%	0%	267 M€
CCM GLOBAL EQUITY ETF - USD	+12.32%	0%	1,199 M€
CLEARSHARES OCIO ETF - DISTRIBUTING - USD	+9.34%	0%	176 M€

DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.

Employees

41,141

Sector

Drug Retailers

Calendar

10-30 Earnings release - Q3 2026

More about the company

Income Statement and Estimates

More financial data

End-of-day quote Shanghai S.E. 28/09/2026			5-day change	1st Jan Change
17.77 ^CNY	+1.25%		-3.32%	+0.85%

09-02	Jefferies Adjusts DaShenLin Pharmaceutical Group's Price Target to 15 Yuan From 12 Yuan, Keeps at Underperform	MT
08-24	DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

ETFs DaShenLin Pharmaceutical Group Co., Ltd.

Stocks

603233

CNE100002RG2

Drug Retailers

ETFs positioned on DaShenLin Pharmaceutical Group Co., Ltd.

Company Profile

Income Statement and Estimates